Ervogastat metabolite M3

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C19H17N5O4
Molecular Weight	379.3694
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC1=CC=CN=C1OC2=CN=CC(=C2)C3=NC=C(C=N3)C(=O)N[C@H]4CCOC4

InChI

InChIKey=NGHYSANESYWITP-AWEZNQCLSA-N

InChI=1S/C19H17N5O4/c25-16-2-1-4-21-19(16)28-15-6-12(7-20-10-15)17-22-8-13(9-23-17)18(26)24-14-3-5-27-11-14/h1-2,4,6-10,14,25H,3,5,11H2,(H,24,26)/t14-/m0/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

(S)-2-(5-((3-Hydroxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide

Preferred Name

English

Ervogastat metabolite M3

Common Name

English

Code System Code Type Description

FDA UNII

GB2PA62UHB

Created by admin on Wed Apr 02 14:23:19 GMT 2025 , Edited by admin on Wed Apr 02 14:23:19 GMT 2025

PRIMARY

PUBCHEM

166451403

Created by admin on Wed Apr 02 14:23:19 GMT 2025 , Edited by admin on Wed Apr 02 14:23:19 GMT 2025

PRIMARY

PARENT (METABOLITE)


					BSOIY5AKQW

ERVOGASTAT

SUBSTANCE RECORD


					GB2PA62UHB

Ervogastat metabolite M3